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BACKGROUND 
Epidermolysis bullosa simplex (EBS) is a dominantly inherited skin disease caused by 
mutations in the keratin 5 (KRT5) or KRT14 genes (1). Some reports suggested that fever 
and/or hot weather may exacerbate EBS phenotype (2). Effective EBS therapies are still 
lacking. Molecular chaperones are proteins whose main function is to promote the correct 
folding of polypeptides (s1). Molecules such as trimethylamine N-oxide (TMAO) and 
sodium 4-phenylbutyrate (4-PBA) act as chemical chaperones (s2) with protein folding 
and stabilization activities (s3, s4, s5). Treatment of affected epidermal cells by chemical 
chaperones to correct the misfolded and aggregated keratins that characterize EBS seems 
a viable therapeutic option (3). Furthermore, the type I keratins K16 and K17 polymerize 
with K5, and upregulation of these proteins could replace the mutant K14 in the 
heterodimer and improve disease pathology (s6). Hence, chemical chaperones which can 
reduce keratin aggregates formation and upregulate K16 and K17 in EBS affected cells 
would be ideal therapeutic candidates for EBS. 
QUESTIONS ADDRESSED 
Investigated the potential therapeutic effects of two chemical chaperones, TMAO and 4-
PBA, in the treatment of EBS by comparing keratin cytoskeleton abnormalities in cells of 
EBS patients and non-EBS participants in a heat shock model; an ideal model as EBS 
patients usually suffer from disease exacerbation in a hot and humid climate (2). 
EXPERIMENTAL DESIGN 
See supplementary information. 
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RESULTS 
TMAO reduced heat-induced keratin aggregates 
To determine if TMAO or 4-PBA had a beneficial effect on EBS keratinocytes, 
cytoplasmic keratin aggregates were evaluated by immunofluorescence. Unstressed or 
heat stressed CTRL cells showed very few or no keratin aggregates (Fig. 1a, b). Of the 
four cell lines, EBS21 cells had the highest increase in the percentage of cells with 
aggregates (42.5%) after heat shock (Fig. S1). EBS21 keratinocytes showed keratin 
aggregates in resting conditions (Fig. 1c) and transient heat-shock led to a collapse of the 
keratin cytoskeleton and an increase of keratin aggregates (Fig. 1d). Pre-treatment of 
EBS21 cells with TMAO at 150mM prior to heat-shock reduced keratin aggregation (Fig. 
1e). Percentage of cells with aggregates decreased from 42.5% (after heat shock) to 
19.5% (p=0.03). Replication assays showed a significant reduction of cells with 
aggregates in EBS10 (p=0.002) but not in EBS1 (Fig. S1). Non-significant aggregates 
reduction was observed in the three EBS cells with pre-treatment of 4-PBA at 10mM 
(data not shown).  
TMAO decreased Hsp70 and Hsp40 protein expression in heat shocked EBS cells 
Protein levels of Hsp70 and Hsp40 were assessed by Western blot to determine if pre-
treatment with TMAO affected their levels in EBS21 and CTRL cells. Our data revealed 
that Hsp70 was 5.5 fold more expressed in unstressed condition in EBS21 compared to 
CTRL and that Hsp40 was not induced (Fig. 2). Heat shock or pre-treatment with TMAO 
alone had no effect on Hsp70 or Hsp40 levels. Pre-treatment with TMAO in heat shocked 
EBS21 cells reduced Hsp70 and Hsp40 expression significantly compared to unstressed 
EBS21 cells (p=0.03 and p=0.05 respectively) (Fig. 2b, d).  
KRT16 and KRT17 expression after TMAO pre-treatment 
Pre-treatment of TMAO in unstressed EBS21 cells did not significantly change KRT16 
and KRT17 gene expression from those without pretreatment. Similar results were 
observed for control cells (data not shown).  
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CONCLUSION 
Our data demonstrated a promising potential for TMAO as a therapeutic agent for EBS 
patients. In this study, TMAO (150mM) partially reduced the percentage of heat-shocked 
EBS cells with aggregates, although it was not able to eliminate all aggregates. TMAO 
may prevent aggregate formation by restoring misfolded proteins (4) or may promote 
protein degradation of misfolded proteins through the ubiquitin-proteasome pathway (5). 
The increase in Hsp70 protein expression observed in unstressed EBS21 as compared to 
control cells may be due to other genetic variations than the KRT14 mutation. However, 
the reduction of Hsp70 and Hsp40 protein level by TMAO and heat shock was not 
observed in control cells suggesting that the mutation is associated with an environment 
in which TMAO functions beneficially. Our data of TMAO reducing Hsp70 and Hsp40 
protein levels is in line with results observed in red blood cells (6). A reduced expression 
of molecular chaperones by TMAO in cells under stress may be explained by a 
preventing effect of TMAO from heat shock damages, reducing the need to elicit the 
cellular heat shock response (6). 
In contrast to our findings, TMAO treatment at 50 and 100mM in two cell lines with 
KRT5 mutations had been shown to induce moderate upregulation of Hsp70 protein 
expression (5). These differences suggest that the mechanism of action of TMAO may be 
dependent on the mutations of the affected cells (7,8) or on the concentration of TMAO 
(5). 
KRT16 and KRT17 gene expression results shown no differences in contrast to the 
increase of K16 and K17 observed in a sulforaphane-treated K14-null mice (9). May be 
gene knock-out will elicit more pronounced biological consequences than a mutated 
gene. 
Although TMAO demonstrated itself as a promising therapeutic candidate for EBS with 
its thermo stress protective role, particularly in those with mutations in KRT5 and KRT14, 
it is worthy to mention that reduction of heat induced aggregates in EBS cells by TMAO 
could simply be with no therapeutic value and no potential benefit to EBS patients. 
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Further mechanistic studies are needed to relate keratin aggregates to stronger and more 
resilient skin. 
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Figures Legends 
Fig. 1 Reduction of keratin aggregates in EBS21 derived keratinocytes by TMAO. 
Intermediate filaments were stained with an anti-K5 antibody in unstressed (a) and heat-
stressed CTRL keratinocytes (b), unstressed (c) and heat-stressed EBS21 keratinocytes 
(d), and TMAO pretreated heat-stressed EBS21 keratinocytes (e). Keratin aggregates are 
marked with arrows. Scale bars=10µm.  
Fig. 2 TMAO reduced Hsp70 and Hsp40 protein levels in heat-stressed EBS21 derived 
keratinocytes. A representative western blot (WB) revealed with anti-Hsp70 (a) and anti-
Hsp40 (c) antibodies comparing cell extracts from CTRL and EBS21 derived 
keratinocytes (-/+) stress and/or (-/+) TMAO as indicated. Graphs show Hsp70 (b) and 
Hsp40 (d) fold difference (FD) compared to unstressed CTRL, for CTRL and EBS21 
keratinocytes in unstressed (US), unstressed and pretreated with TMAO (US+TMAO), 
heat-stressed (HS) and heat-stressed and pretreated (HS+TMAO) conditions. Results 
represent the mean + SD for Hsp70 (n=3) and for Hsp40 (n=4) independent experiments. 
Statistical significance was set at p≤0.05. 
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Fig. 1 Reduction of keratin aggregates in EBS21 derived keratinocytes by TMAO. Intermediate filaments 
were stained with an anti-K5 antibody in unstressed (a) and heat-stressed CTRL keratinocytes (b), 
unstressed (c) and heat-stressed EBS21 keratinocytes (d), and TMAO pretreated heat-stressed EBS21 
keratinocytes (e). Keratin aggregates are marked with arrows. Scale bars=10µm.  
73x78mm (300 x 300 DPI)  
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Fig. S1 Quantification of keratin aggregates in EBS keratinocyte cell lines. Graph depicts the percentage of 
keratinocytes showing keratin aggregates in CTRL, EBS21, EBS1 and EBS10 unstressed (US), heat-stressed 
(HS) or TMAO pretreated keratinocytes with heat-stress (TMAO+HS). Results represent the mean + SD of 
three independent experiments (500 cells were counted for each experiment). Statistical significance was 
set at p≤0.05.  
34x34mm (300 x 300 DPI)  
Page 11 of 28
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Fig. 2 TMAO reduced Hsp70 and Hsp40 protein levels in heat-stressed EBS21 derived keratinocytes. A 
representative western blot (WB) revealed with anti-Hsp70 (a) and anti-Hsp40 (c) antibodies comparing cell 
extracts from CTRL and EBS21 derived keratinocytes (-/+) stress and/or (-/+) TMAO as indicated. Graphs 
show Hsp70 (b) and Hsp40 (d) fold difference (FD) compared to unstressed CTRL, for CTRL and EBS21 
keratinocytes in unstressed (US), unstressed and pretreated with TMAO (US+TMAO), heat-stressed (HS) 
and heat-stressed and pretreated (HS+TMAO) conditions. Results represent the mean + SD for Hsp70 (n=3) 
and for Hsp40 (n=4) independent experiments. Statistical significance was set at p≤0.05.  
145x261mm (300 x 300 DPI)  
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Supporting Information 
Additional supporting data may be found in the supplementary information of this article. 
Data S1. Material and methods 
Table S1.Clinical status and mutations found in three EBS cases 
Figure S1. Quantification of keratin aggregates in EBS keratinocyte lines 
Additional references 
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Supporting information 
Data S1: Materials and methods 
Immortalized keratinocytes establishment 
We established four new primary and stable keratinocyte cell lines from one healthy 
control (CTRL) and from one severely affected generalized EBS-DM patient (EBS 
Dowling-Meara) (EBS21), with a p.Arg125Ser substitution in K14 that we previously 
genetically defined (s7). The two others EBS cell lines (EBS1 and EBS10) have a 
p.Ile377Thr and a p.Ile412Phe substitution respectively (Table S1). The ethic committee
from the Hôpital Sainte-Justine and from the Centre intégré de santé et de services 
sociaux du Saguenay–Lac-Saint-Jean approved the study and the four individuals gave 
their informed consent. 
Primary cultures were established from non-blistered skin using standard protocols. Cells 
were maintained in standard keratinocyte tissue culture medium containing Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 25% Ham’s F12 medium, 10% 
fetal calf serum, 0.4 µg/ml hydrocortisone, 10
-10 
M cholera toxin, 5 µg/ml human
transferrin, 1.3 ng/ml thyronine, 24.3 µg/ml adenine, 5 µg/ml bovine insulin, 10 ng/ml 
human recombinant epidermal growth factor and cultured on 3T3 fibroblast feeder cells. 
Primary keratinocyte lines were immortalized by co-plating with mitomycin C-treated 
PT67 retroviral producer cells producing a recombinant retrovirus expressing E6 and E7 
(kindly provided by Dr. Baki Akgul, Institute of Virology, University of Cologne, 
Cologne, Germany). Three to four days later, producer cells were selectively removed 
and mitomycin C-treated 3T3 feeder cells were added to the culture, a day prior to 
selection. Transductants were selected with G418 (70-100 µg/ml for 5 days). When cells 
became independent, they were routinely cultured in the standard medium described 
above. To limit the impact of further genetic variations, immortalized EBS21, EBS1 and 
EBS10 cells were evaluated for the presence of the characteristic R125S, I377T or I412F 
(K14) mutation (data not shown) and all experiments were carried out on cells with 
almost identical passages between control and EBS (5-8 passages after immortalisation). 
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Keratinocyte lines heat-shock and pretreatment with TMAO and 4-PBA 
Immortalized EBS21 and CTRL keratinocytes were cultured in 24-well plates on 13mm 
coverslips in duplicates, and then were subjected to thermal stress as previously described 
with some modiﬁcations (5). Brieﬂy, cells were heat-shocked at 43°C for 35 min 
followed by a recovery period of 15 min. Dose-response curves were established for each 
molecule to determine the optimal dose and time of incubation. Three assays per 
molecule were performed as follow, keratinocytes were pretreated with one of the two 
chemical molecules trimethylamine N-oxide (TMAO) (150mM, Sigma-Aldrich) or 
sodium 4-phenylbutyrate (4-PBA) (10mM, Calbiochem), dissolved in culture medium 
and subsequently cultured for 24 h prior to thermal stress. Cells were then processed for 
immunofluorescence staining. As a difference was observed for TMAO, replication 
assays for TMAO were done with immortalized EBS1 and EBS10 cell lines. 
Immunofluorescence 
Coverslips were washed with PBS, then fixed in 4% paraformaldehyde in PBS for 15 min 
and permeabilized for 4 min at room temperature with Triton stabilization buffer (PBS, 
0.2% Triton X-100). Unspeciﬁc binding epitopes were blocked with 5% normal goat 
serum, 5% bovine serum albumin (BSA) in PBS for 30 min. Subsequently, cells were 
incubated for 90 min with an anti-K5 antibody diluted in a blocking solution (1% BSA in 
PBS) (Clone XM26, 1:65 dilution; Cedarlane, ON, Canada). Then, cells were incubated 
for 45 min with a Cy3-conjugated goat anti-mouse antibody (1:800 dilution; Cedarlane, 
ON, Canada). Following PBS washes, coverslips were mounted on glass slides using 
Dako fluorescent mounting medium (Dako). Slides were examined under an inverted 
fluorescence microscope (AxioObserver, Zeiss, Germany) and 500 cells were counted for 
all the conditions in each experiment in the duplicate coverslips. Pictures of 
representative fields were taken using the AxioVision software (Rel. 4.8, Zeiss, 
Germany). Data analysis was performed using Student’s t-test. Results are expressed as 
mean of cells with aggregates ± SD. Statistical significance was assumed for P≤0.05. 
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qRT-PCR 
KRT16 and KRT17 mRNA expression by quantitative real-time PCR (qRT-PCR) was 
done in triplicate with negative controls with or without TMAO pre-treatment for the 
CTRL, EBS21, EBS1 and EBS10 cell lines with no heat stress applied to the cells. 
Briefly, total RNA was extracted from confluent cell layers using the RNeasy plus Mini 
Kit (Qiagen, ON, Canada) according to manufacturer's recommendations. qScript™ 
cDNA SuperMix (Quanta Biosciences, MD, USA) with oligodT(20) primers were used 
for cDNA synthesis. The RT-PCR reaction was performed using TaqMan technology in 
the Rotor-Gene 6000 (Corbett Research, Sydney, Australia) with 0.67ng of cDNA, 
TaqMan primers (Applied Biosystems, ON, Canada) and PerfecTa qPCR ThoughMix 
(Quanta Biosciences, MD, USA) for a final volume of 20µl. Each sample was done in 
triplicates with a negative control. Quantification of gene expression was performed 
using the two standard curves method and significant differences of expression were 
assessed using the Student’s t-test (P≤0.05). Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was used as a housekeeping gene. 
Cell lysates preparation and Western Blot 
Cell lysates in each experimental condition were prepared as described elsewhere (4). 
Cells were washed twice in cold PBS and scraped after addition of lysis buffer (20mM 
Tris pH 7.5, 0.5% (w/v) Triton X-100, 0.5% (w/v) deoxycholate, 10mM EDTA, 30mM 
sodium pyrophosphate, 150mM NaCl, 0.5mM sodium orthovanadate, 1mM 
phenylmethylsulfonyl fluoride (PMSF), 0.5ng/ml aprotinin, 0.5ng/ml leupeptin and 
0.64mM benzamidine). Cell suspensions were incubated on ice for 30 min, with periodic 
vortexing. Cell lysates were then centrifuged at 15 000gmax at 4°C for 30 min. 
Supernatants were collected and subjected to Bradford assay to determine protein 
concentration using a bovine serum albumin standard curve. Ten to fifteen micrograms 
(for Hsp70) and 30-40 micrograms (for Hsp40) of proteins after addition of Laemmli 
sample buffer were heated at 95°C for 5 min and were loaded on Stain-free
TM
 gel and
then transferred to TransBlot
®
Turbo
TM
PVDF membranes (Bio-Rad, Canada). Western
blot were performed in TBST-5% powder milk using anti-Hsp70 (clone C92F3A-5, 
dilution 1/10 000, Assay designs, ON, Canada) or anti-Hsp40 (clone EPR1530, dilution 
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5 
1/1000, Abcam, ON, Canada). Proteins were revealed by chemiluminescence and 
quantified with Image Lab
TM 
software, which is included with the ChemiDoc
TM
 MP
imaging system (Bio-Rad, Canada). Quantification of the Hsp70 and Hsp40 protein 
levels was performed according to a published protocol using Image Lab
TM 
software (s8).
In each experiment, the fold difference was determined as described in Taylor SC and 
Posch A (2014) (s9), using untreated CTRL as the reference.  The mean of fold 
difference values and its standard deviation (SD) were calculated. Statistical analysis was 
performed using the Student’s t-test (P≤0.05). 
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Table S1 Clinical status and mutations found in three EBS cases 
Figure legend 
Fig. S1 Quantification of keratin aggregates in EBS keratinocyte cell lines. Graph depicts 
the percentage of keratinocytes showing keratin aggregates in CTRL, EBS21, EBS1 and 
EBS10 unstressed (US), heat-stressed (HS) or TMAO pretreated keratinocytes with heat-
stress (TMAO+HS). Results represent the mean + SD of three independent experiments 
(500 cells were counted for each experiment). Statistical significance was set at p≤0.05. 
Case Sex EBS 
subtype 
KRT14
mutation 
K14 
mutation 
Exon Domain Reference 
EBS21 Male EBS 
Dowling-
Meara 
373C>A R125S 1 1A (s7) 
EBS1 Male EBS 
Localized 
1130T>C I377T 6 2B (s10) 
EBS10 Female EBS 
Localized 
1295A>T I412F 6 2B (s11) 
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Supporting Information 
Additional supporting data may be found in the supplementary information of this article. 
Data S1. Material and methods 
Table S1.Clinical status and mutations found in three EBS cases 
Figure S1. Quantification of keratin aggregates in EBS keratinocyte lines 
Additional references 
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Supporting information 
Data S1: Materials and methods 
Immortalized keratinocytes establishment 
We established four new primary and stable keratinocyte cell lines from one healthy 
control (CTRL) and from one severely affected generalized EBS-DM patient (EBS 
Dowling-Meara) (EBS21), with a p.Arg125Ser substitution in K14 that we previously 
genetically defined (s7). The two others EBS cell lines (EBS1 and EBS10) have a 
p.Ile377Thr and a p.Ile412Phe substitution respectively (Table S1). The ethic committee
from the Hôpital Sainte-Justine and from the Centre intégré de santé et de services 
sociaux du Saguenay–Lac-Saint-Jean approved the study and the four individuals gave 
their informed consent. 
Primary cultures were established from non-blistered skin using standard protocols. Cells 
were maintained in standard keratinocyte tissue culture medium containing Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 25% Ham’s F12 medium, 10% 
fetal calf serum, 0.4 µg/ml hydrocortisone, 10
-10 
M cholera toxin, 5 µg/ml human
transferrin, 1.3 ng/ml thyronine, 24.3 µg/ml adenine, 5 µg/ml bovine insulin, 10 ng/ml 
human recombinant epidermal growth factor and cultured on 3T3 fibroblast feeder cells. 
Primary keratinocyte lines were immortalized by co-plating with mitomycin C-treated 
PT67 retroviral producer cells producing a recombinant retrovirus expressing E6 and E7 
(kindly provided by Dr. Baki Akgul, Institute of Virology, University of Cologne, 
Cologne, Germany). Three to four days later, producer cells were selectively removed 
and mitomycin C-treated 3T3 feeder cells were added to the culture, a day prior to 
selection. Transductants were selected with G418 (70-100 µg/ml for 5 days). When cells 
became independent, they were routinely cultured in the standard medium described 
above. To limit the impact of further genetic variations, immortalized EBS21, EBS1 and 
EBS10 cells were evaluated for the presence of the characteristic R125S, I377T or I412F 
(K14) mutation (data not shown) and all experiments were carried out on cells with 
almost identical passages between control and EBS (5-8 passages after immortalisation). 
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Keratinocyte lines heat-shock and pretreatment with TMAO and 4-PBA 
Immortalized EBS21 and CTRL keratinocytes were cultured in 24-well plates on 13mm 
coverslips in duplicates, and then were subjected to thermal stress as previously described 
with some modiﬁcations (5). Brieﬂy, cells were heat-shocked at 43°C for 35 min 
followed by a recovery period of 15 min. Dose-response curves were established for each 
molecule to determine the optimal dose and time of incubation. Three assays per 
molecule were performed as follow, keratinocytes were pretreated with one of the two 
chemical molecules trimethylamine N-oxide (TMAO) (150mM, Sigma-Aldrich) or 
sodium 4-phenylbutyrate (4-PBA) (10mM, Calbiochem), dissolved in culture medium 
and subsequently cultured for 24 h prior to thermal stress. Cells were then processed for 
immunofluorescence staining. As a difference was observed for TMAO, replication 
assays for TMAO were done with immortalized EBS1 and EBS10 cell lines. 
Immunofluorescence 
Coverslips were washed with PBS, then fixed in 4% paraformaldehyde in PBS for 15 min 
and permeabilized for 4 min at room temperature with Triton stabilization buffer (PBS, 
0.2% Triton X-100). Unspeciﬁc binding epitopes were blocked with 5% normal goat 
serum, 5% bovine serum albumin (BSA) in PBS for 30 min. Subsequently, cells were 
incubated for 90 min with an anti-K5 antibody diluted in a blocking solution (1% BSA in 
PBS) (Clone XM26, 1:65 dilution; Cedarlane, ON, Canada). Then, cells were incubated 
for 45 min with a Cy3-conjugated goat anti-mouse antibody (1:800 dilution; Cedarlane, 
ON, Canada). Following PBS washes, coverslips were mounted on glass slides using 
Dako fluorescent mounting medium (Dako). Slides were examined under an inverted 
fluorescence microscope (AxioObserver, Zeiss, Germany) and 500 cells were counted for 
all the conditions in each experiment in the duplicate coverslips. Pictures of 
representative fields were taken using the AxioVision software (Rel. 4.8, Zeiss, 
Germany). Data analysis was performed using Student’s t-test. Results are expressed as 
mean of cells with aggregates ± SD. Statistical significance was assumed for P≤0.05. 
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qRT-PCR 
KRT16 and KRT17 mRNA expression by quantitative real-time PCR (qRT-PCR) was 
done in triplicate with negative controls with or without TMAO pre-treatment for the 
CTRL, EBS21, EBS1 and EBS10 cell lines with no heat stress applied to the cells. 
Briefly, total RNA was extracted from confluent cell layers using the RNeasy plus Mini 
Kit (Qiagen, ON, Canada) according to manufacturer's recommendations. qScript™ 
cDNA SuperMix (Quanta Biosciences, MD, USA) with oligodT(20) primers were used 
for cDNA synthesis. The RT-PCR reaction was performed using TaqMan technology in 
the Rotor-Gene 6000 (Corbett Research, Sydney, Australia) with 0.67ng of cDNA, 
TaqMan primers (Applied Biosystems, ON, Canada) and PerfecTa qPCR ThoughMix 
(Quanta Biosciences, MD, USA) for a final volume of 20µl. Each sample was done in 
triplicates with a negative control. Quantification of gene expression was performed 
using the two standard curves method and significant differences of expression were 
assessed using the Student’s t-test (P≤0.05). Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was used as a housekeeping gene. 
Cell lysates preparation and Western Blot 
Cell lysates in each experimental condition were prepared as described elsewhere (4). 
Cells were washed twice in cold PBS and scraped after addition of lysis buffer (20mM 
Tris pH 7.5, 0.5% (w/v) Triton X-100, 0.5% (w/v) deoxycholate, 10mM EDTA, 30mM 
sodium pyrophosphate, 150mM NaCl, 0.5mM sodium orthovanadate, 1mM 
phenylmethylsulfonyl fluoride (PMSF), 0.5ng/ml aprotinin, 0.5ng/ml leupeptin and 
0.64mM benzamidine). Cell suspensions were incubated on ice for 30 min, with periodic 
vortexing. Cell lysates were then centrifuged at 15 000gmax at 4°C for 30 min. 
Supernatants were collected and subjected to Bradford assay to determine protein 
concentration using a bovine serum albumin standard curve. Ten to fifteen micrograms 
(for Hsp70) and 30-40 micrograms (for Hsp40) of proteins after addition of Laemmli 
sample buffer were heated at 95°C for 5 min and were loaded on Stain-free
TM
 gel and
then transferred to TransBlot
®
Turbo
TM
PVDF membranes (Bio-Rad, Canada). Western
blot were performed in TBST-5% powder milk using anti-Hsp70 (clone C92F3A-5, 
dilution 1/10 000, Assay designs, ON, Canada) or anti-Hsp40 (clone EPR1530, dilution 
Page 24 of 28
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
5 
1/1000, Abcam, ON, Canada). Proteins were revealed by chemiluminescence and 
quantified with Image Lab
TM 
software, which is included with the ChemiDoc
TM
 MP
imaging system (Bio-Rad, Canada). Quantification of the Hsp70 and Hsp40 protein 
levels was performed according to a published protocol using Image Lab
TM 
software (s8).
In each experiment, the fold difference was determined as described in Taylor SC and 
Posch A (2014) (s9), using untreated CTRL as the reference. The mean of fold difference 
values and its standard deviation (SD) were calculated. Statistical analysis was performed 
using the Student’s t-test (P≤0.05). 
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Table S1 Clinical status and mutations found in three EBS cases 
Figure legend 
Fig. S1 Quantification of keratin aggregates in EBS keratinocyte cell lines. Graph depicts 
the percentage of keratinocytes showing keratin aggregates in CTRL, EBS21, EBS1 and 
EBS10 unstressed (US), heat-stressed (HS) or TMAO pretreated keratinocytes with heat-
stress (TMAO+HS). Results represent the mean + SD of three independent experiments 
(500 cells were counted for each experiment). Statistical significance was set at p≤0.05. 
Case Sex EBS 
subtype 
KRT14
mutation 
K14 
mutation 
Exon Domain Reference 
EBS21 Male EBS 
Dowling-
Meara 
373C>A R125S 1 1A (s7) 
EBS1 Male EBS 
Localized 
1130T>C I377T 6 2B (s10) 
EBS10 Female EBS 
Localized 
1295A>T I412F 6 2B (s11) 
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